Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Evan R. Goldfischer

Urology
Premier Medical Group Of The Hudson Valley PC
1 Webster Ave, Suite 301, 
Poughkeepsie, NY 

Experienced in WT1-Related Wilms Tumor Syndromes
Premier Medical Group Of The Hudson Valley PC
1 Webster Ave, Suite 301, 
Poughkeepsie, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Evan Goldfischer is an Urologist in Poughkeepsie, New York. Dr. Goldfischer is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Enlarged Prostate (BPH), Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Bladder Reconstruction.

His clinical research consists of co-authoring 23 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in NY
Hospital Affiliations
Westchester Medical Center
Northern Dutchess Hospital
Vassar Brothers Medical Center
Sharon Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

PREMIER MEDICAL GROUP OF THE HUDSON VALLEY PC
1 Webster Ave, Suite 301, Poughkeepsie, NY 12601
Call: 845-790-6100
Other Locations
PREMIER MEDICAL GROUP OF THE HUDSON VALLEY PC
243 N Rd, Poughkeepsie, NY 12601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drugs: ALT-803, Bacillus Calumette-Guerin
Study Phase: Phase 2/Phase 3
VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent
VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent
Enrollment Status: Terminated
Publish Date: February 05, 2024
Intervention Type: Drug
Study Drugs: VERU-111, Enzalutamide, Abiraterone, Darolutamide and Apalutamide
Study Phase: Phase 3
A Multicenter, Dose-Ranging Trial Evaluating the Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis
A Multicenter, Dose-Ranging Trial Evaluating the Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug
Study Phase: Phase 2
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Enrollment Status: Completed
Publish Date: September 01, 2022
Intervention Type: Other
A Pilot Multicenter, Randomized, Double-Blind Study Comparing The Proportion Of Responders to PSD502 and to Placebo Using the PEBEQ In Subjects With Premature Ejaculation
A Pilot Multicenter, Randomized, Double-Blind Study Comparing The Proportion Of Responders to PSD502 and to Placebo Using the PEBEQ In Subjects With Premature Ejaculation
Enrollment Status: Completed
Publish Date: July 05, 2022
Intervention Type: Drug
Study Drug: PSD502
Study Phase: Phase 2
Long-Term Prospective Registry to Evaluate Treatment Decisions and Clinical Outcomes in Patients With Favorable Intermediate-Risk Localized Prostate Cancer Following Cell Cycle Progression (CCP) Testing (Prolaris® Test)
Long-Term Prospective Registry to Evaluate Treatment Decisions and Clinical Outcomes in Patients With Favorable Intermediate-Risk Localized Prostate Cancer Following Cell Cycle Progression (CCP) Testing (Prolaris® Test)
Enrollment Status: Terminated
Publish Date: June 23, 2022
Intervention Type: Diagnostic test
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Enrollment Status: Completed
Publish Date: February 28, 2022
Intervention Type: Device, Procedure
Study Phase: Not Applicable
A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men With Metastatic Castration Resistant Prostate Cancer
A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men With Metastatic Castration Resistant Prostate Cancer
Enrollment Status: Completed
Publish Date: May 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer
A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer
Enrollment Status: Terminated
Publish Date: August 28, 2019
View 8 Less Clinical Trials

23 Total Publications

Prolonged Progression-Free Survival, Disease-Free Survival and Cystectomy Avoidance with IL-15 Receptor Lymphocyte-Stimulating Agent NAI plus BCG in BCG-Unresponsive Papillary-Only NMIBC.
Prolonged Progression-Free Survival, Disease-Free Survival and Cystectomy Avoidance with IL-15 Receptor Lymphocyte-Stimulating Agent NAI plus BCG in BCG-Unresponsive Papillary-Only NMIBC.
Journal: The Journal of urology
Published: September 16, 2025
View All 23 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Louis R. Kavoussi
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Louis R. Kavoussi
Urology

North Shore-Lij Medical PC

101 Saint Andrews Ln, 
Glen Cove, NY 
 (60.6 miles away)
631-675-4550
Languages Spoken:
English
See accepted insurances

Louis Kavoussi is an Urologist in Glen Cove, New York. Dr. Kavoussi is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael D. Stifelman
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael D. Stifelman
Urology

Hackensack Meridian Health Medical Group - Specialty Care PC

360 Essex St, 
Hackensack, NJ 
 (58.1 miles away)
201-336-8686
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Stifelman is an Urologist in Hackensack, New Jersey. Dr. Stifelman is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), UPJ Obstruction, Retroperitoneal Fibrosis, Nephrectomy, and Ureteral Reconstruction.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Paul K. Pietrow
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Paul K. Pietrow
Urology

Premier Medical Group Of The Hudson Valley PC

955 Little Britain Rd, 
New Windsor, NY 
 (18.0 miles away)
845-437-5000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Paul Pietrow is an Urologist in New Windsor, New York. Dr. Pietrow is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Perirenal Abscess, Boils, Renal Cell Carcinoma (RCC), Ureteroscopy, and Reconstructive Urology Surgery.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Goldfischer's expertise for a condition
ConditionClose
  • Elite
  • Enlarged Prostate (BPH)
    Dr. Goldfischer is
    Elite
    . Learn about Enlarged Prostate (BPH).
    See more Enlarged Prostate (BPH) experts
  • Distinguished
  • Boils
    Dr. Goldfischer is
    Distinguished
    . Learn about Boils.
    See more Boils experts
  • Carbuncle
    Dr. Goldfischer is
    Distinguished
    . Learn about Carbuncle.
    See more Carbuncle experts
  • Familial Prostate Cancer
    Dr. Goldfischer is
    Distinguished
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Folliculitis
    Dr. Goldfischer is
    Distinguished
    . Learn about Folliculitis.
    See more Folliculitis experts
  • Kidney Stones
    Dr. Goldfischer is
    Distinguished
    . Learn about Kidney Stones.
    See more Kidney Stones experts
  • Muscle Invasive Bladder Cancer
    Dr. Goldfischer is
    Distinguished
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
View All 12 Distinguished Conditions
  • Advanced
  • Bilateral Hydronephrosis
    Dr. Goldfischer is
    Advanced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Bladder Cancer
    Dr. Goldfischer is
    Advanced
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Bladder Stones
    Dr. Goldfischer is
    Advanced
    . Learn about Bladder Stones.
    See more Bladder Stones experts
  • Empyema
    Dr. Goldfischer is
    Advanced
    . Learn about Empyema.
    See more Empyema experts
  • Eunuchoidism Familial Hypogonadotropic
    Dr. Goldfischer is
    Advanced
    . Learn about Eunuchoidism Familial Hypogonadotropic.
    See more Eunuchoidism Familial Hypogonadotropic experts
  • Frequent or Urgent Urination
    Dr. Goldfischer is
    Advanced
    . Learn about Frequent or Urgent Urination.
    See more Frequent or Urgent Urination experts
View All 18 Advanced Conditions
  • Experienced
  • Bacterial Prostatitis
    Dr. Goldfischer is
    Experienced
    . Learn about Bacterial Prostatitis.
    See more Bacterial Prostatitis experts
  • Balanitis
    Dr. Goldfischer is
    Experienced
    . Learn about Balanitis.
    See more Balanitis experts
  • Bladder Reconstruction
    Dr. Goldfischer is
    Experienced
    . Learn about Bladder Reconstruction.
    See more Bladder Reconstruction experts
  • Choriocarcinoma
    Dr. Goldfischer is
    Experienced
    . Learn about Choriocarcinoma.
    See more Choriocarcinoma experts
  • Chromophobe Renal Cell Carcinoma
    Dr. Goldfischer is
    Experienced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Goldfischer is
    Experienced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
View All 38 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved